Approaches to chemical synthetic biology  by Chiarabelli, Cristiano et al.
FEBS Letters 586 (2012) 2138–2145journal homepage: www.FEBSLetters .orgReview
Approaches to chemical synthetic biology
Cristiano Chiarabelli 1, Pasquale Stano 1, Fabrizio Anella, Paolo Carrara, Pier Luigi Luisi ⇑
Biology Department, University of Roma Tre, Viale Guglielmo Marconi 446, 00146 Rome, Italy
a r t i c l e i n f oOpen access under CC BY-NC-ND license.Article history:
Received 4 January 2012
Accepted 10 January 2012
Available online 17 January 2012
Edited by Thomas Reiss and Wilhelm Just
Keywords:
Minimal Cell
Lipid vesicle
Random sequence
RNA stability
Protein folding0014-5793  2012 Federation of European Biochemic
doi:10.1016/j.febslet.2012.01.014
⇑ Corresponding author. Fax: +39 0657336329.
E-mail address: luisi@mat.ethz.ch (P.L. Luisi).
1 These two authors have contributed equally to thia b s t r a c t
Synthetic biology is ﬁrst represented in terms of two complementary aspects, the bio-engineering
one, based on the genetic manipulation of extant microbial forms in order to obtain forms of life
which do not exist in nature; and the chemical synthetic biology, an approach mostly based on
chemical manipulation for the laboratory synthesis of biological structures that do not exist in nat-
ure. The paper is mostly devoted to shortly review chemical synthetic biology projects currently car-
ried out in our laboratory. In particular, we describe: the minimal cell project, then the ‘‘Never Born
Proteins’’ and lastly the Never Born RNAs. We describe and critically analyze the main results,
emphasizing the possible relevance of chemical synthetic biology for the progress in basic science
and biotechnology.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The notion of synthetic biology (SB) is by nowwell accredited in
the experimental life sciences, and is generally seen as the modern
and most ambitious development of bioengineering and biotech-
nology in general. The term ambitious is appropriate, as one of
the declared aims of SB is the laboratory construction of alternative
forms of life, namely forms of life that do not exist in nature. The
term life is till now still restricted to microorganisms, and various
aspects of this design have been described in the literature about
microbes capable of eventually producing fuels and energy for
mankind, to the various genomic modiﬁcations of extant microor-
ganisms to enrich their functionality [1–3]. Those are all manipula-
tions of extant bacteria and it is fair to say at this point that
ambition has been restricted to this – namely manipulation of ex-
tant forms of life. The claim to have synthesized new life ‘‘simply’’
by replacing a synthetic genome with the original one [4] cannot
be really called new synthetic life – it is a kind of organ transplant
– as skillful and admirable as it is.
All this has to do with genetic manipulation of one sort or
another, an enterprise that for some is not exempt from bioethical
problems – particularly if in a non-distant future we begin to play
with multicellular and higher organisms.
Togetherwith this bioengineering-genetic aspect, SB has another
aspect, which is more oriented towards basic science. This has to do
with the question ‘‘why nature did this and not that’’ – why there isal Societies. Published by Elsevier
s review.ribose in nucleic acids and not glucose; why we have proteins with
20 amino acids and not with 10 or 15; whywe have the proteins we
have, and not all the others. . . And the beauty of SB is the possibility
to answer, or at least, tackle these questions with experimental
laboratory means: just making ‘‘that’’ and comparing it with ‘‘this’’,
withwhatwehave. In thisway,wemay discover – this is the claim–
why nature went into one avenue and discarded the others.
Thus, nucleic acids with pyranose instead of ribose have been
synthesized by Eschenmoser and his group [5], proteins with a re-
duced alphabet of amino acids have been prepared and studied by
Doi [6]; and nucleic acid alphabet different from the extant ones
have been also studied by Benner and collaborators [7].
In this kind of SB, chemistry more than genetic manipulation is
the main tool, and in fact the term ‘‘chemical synthetic biology’’
has been coined to describe this particular ﬁeld [8–10]. The episte-
mology, which is at the basis of the discrimination between these
two sub-ﬁelds of SB, has been also the subject of study [11].
The present article is devoted to chemical SB, and in particular
to the two research areas which we have been developing over the
latest years, namely the project ‘‘minimal cell’’/‘‘minimal life’’; and
the project ‘‘Never Born Proteins’’/‘‘Never Born RNAs’’. Introduction
to these terms is given below. For the other aspects of chemical SB
the reader is referred to a recent volume [10].
2. The minimal cell: from origin of life to synthetic biology
The notion of ‘‘minimal’’ cell can be approached from several
viewpoints, with many overlapping concepts. Traditionally, in the
origin of life community the interest is focused on the ﬁrst
primitive living cell [12,13]. It is reasonable to assume that suchB.V. Open access under CC BY-NC-ND license.
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plexity has been shaped by the evolution. However, despite their
simplicity when compared with modern cells, primitive living cells
were still able to perform basic functions that are characteristic of
living organisms, such as self-maintenance and self-reproduction,
and they were also able to evolve into more complex cells. Think-
ing to their structure and functions, therefore, primitive living cells
were also ‘‘minimal’’ in the sense that they were able to act as liv-
ing systems, but with a minimal molecular complexity. From this
viewpoint, an important question would be: how do we study
the origin of cellular life in the absence of the ‘‘object’’ of the inves-
tigation? Primitive minimal cells do not exist anymore and for this
reason a possible experimental approach involves synthetic (con-
structive) biology as a theoretical and experimental framework
to develop our understanding on the origin of cellular life. The next
question becomes: is it possible to observe experimentally the
emergence of minimal primitive cells in reconstructed pre-biotic
conditions and using only allegedly pre-biotic functional com-
pounds? Unfortunately, no one knows the answer, but the research
activities associated to this question are ﬂourishing recently [14–
17]. The major limitation factor is – in this context – the unavail-
ability of prebiotically plausible molecular components that are re-
quired for establishing an autopoietic (self-producing) dynamics
[18,19]. For example, a very well known scenario proposed for
the origin of life foresees the onset of the so-called RNA world
[20], where RNA molecules could act simultaneously as storage
of genetic information (in their primary sequence) as well as cata-
lysts for primitive metabolic transformations (i.e., the case of RNA
enzymes or ribozymes). A possible molecular system based on
ribozymes inside primitive cell-like compartments has been pro-
posed [21], but it lies outside our current experimental possibili-
ties, due to the fact that the kinds of ribozymes required for this
assembly have not been discovered yet, and – moreover – it is
not very clear how long RNA strands could originate from the
building blocks. A scenario for the emergence of long and possibly
catalytic biopolymers, such as polypeptides and polynucleotides,
might involve a fragment condensation (ligation) pathway, possi-
bly helped by spontaneously formed small catalysts (organocata-
lysts); see a short discussion in Box 1.
An alternative approach to the construction of minimal cells in
the laboratory involves the use of ‘‘modern’’ macromolecules such
as DNA, RNA, and proteins which are experimentally available and
their assembly in form of a synthetic compartment, such as a lipid
vesicle (liposome). This approach, which has been started in our
research group in Zurich in the early Nineties, is generally known
as semi-synthetic. In addition to be quite attractive for its feasibility,
modularity and possible development into future biotechnological
applications (making it quite well ﬁtting with the SB philosophy of
parts, devices and systems [27]), the semi-synthetic approach is
also very useful for answering the question of the emergence of
cellular life. In this context, in fact, the focus is shifted from the
chemical nature of primitive cell components (need to be prebiot-
ically plausible) to the design and construction of a minimal self-
organizing autopoietic network within cell-like compartments,
by means of modern molecules. Clearly, semi-synthetic minimal
cells cannot be a realistic model of primitive cells, nevertheless this
approach might help to understand the critical features of the
dynamic organization of cells, and to demonstrate experimentally
that non-living molecules can produce a living entity as soon as the
minimal requirements for life are met.
2.1. The technology of semi-synthetic minimal cells
The general idea behind semi-synthetic minimal cells is illus-
trated in Fig. 1a. The minimal number of DNA genes, RNAs,
enzymes, and low molecular-weight compounds are entrappedwithin a lipid vesicles so that a compartment is formed, which
might display some of the basic features of living cells. Which func-
tions need to be reconstructed in semi-synthetic minimal cells?
Clearly, this depends on the goals of the experimenters, as they
can go from ‘‘simple’’ functions like the synthesis of one enzyme,
to more complex ones as sensing the environment and trigger an
internal response, or even to the synchronized core-and-shell
reproduction of the whole construct (achieved by self-producing
all molecules required for the internalized network as well as the
lipid molecules that constitute the membrane boundary). In order
to be deﬁned as ‘‘alive’’ a semi-synthetic minimal cell should func-
tion as an autonomous living cell, based on what is known as min-
imal genome. Based on comparative genomics, several studies have
pointed out that the minimal number of genes for a viable cell can
be derived by looking at the genomes of the smallest microorgan-
isms, which are parasites or endosymbionts. For example, the
small obligate parasite Mycoplasma genitalium has a genome of
517 genes with only 470 predicted coding regions [32]. It has been
recently proposed that the minimal genome would consist in 208
genes [33], half of which involved in protein synthesis and process-
ing. The remaining ones are for energy and metabolic processes,
DNA and membrane synthesis.
To date, the construction of a synthetic cell containing about
two hundred genes is out of reach. Also, it is not useful to try to
construct a very complex system without understanding how
works a simpler one. Actually, since one of the major advantages
of using a SB approach consists in ‘‘learning by constructing’’ (as
opposite to learning by analyzing – i.e. dissecting – existing
objects), it turns that the stepwise construction of semi-synthetic
systems of increasing complexity will reveal what are the critical-
ities in assembling a cell-like dynamic systems with an autopoietic
design, and how these were solved during the course of pre-biotic
and biological evolution.
The current state-of-the-art of minimal cell research deals with
the synthesis of proteins inside lipid vesicles. This step is consid-
ered as crucial for the whole project on synthetic cells because it
will permit the in situ production of functions for all aspects of
the cell self-maintenance and self-reproduction. To date, several
enzymes have been produced inside lipid vesicles. The experimen-
tal approach derives from the joining of cell-free technology and
liposome technology. It is foreseeable that in the near future this
match will be further enriched by microﬂuidic technology, due to
the very recent advancements in the ﬁeld of giant vesicle prepara-
tion in microﬂuidic devices [34–38]. The present experimental
approach generally involves the formation of liposomes in a solu-
tion containing all components required to be encapsulated and
therefore needed for establishing the biochemical reactivity inside
a minimal cell. At this aim, cell extracts or reconstituted cell-free
systems are used. In particular, the PURE system (Protein synthesis
Using Recombinant Elements), introduced by the group of Ueda in
2001 [28,29], represents the standard SB ‘‘module’’ for synthesizing
proteins inside liposomes, being composed by 36 puriﬁed en-
zymes/translation factors, puriﬁed ribosomes and tRNAs (see
Fig. 1a caption). The PURE system is composed by the minimal
number of molecular components required for the synthesis of a
functional protein.
Among the various liposome preparation methods [39], the
most used one are the classical ﬁlm hydration method [40], the
hydration of freeze-dried liposomes [41], and the ethanol injection
method [31]. These methods have been applied to the construction
of semi-synthetic minimal cells capable of producing several pro-
teins and enzymes, such as the green ﬂuorescent protein (GFP)
[40–42], T7 RNA polymerase [43], a-hemolysin [44], Qb-replicase
[17], b-galactosidase [45], and two membrane-bound acyltransfer-
ases [46]. Thanks to these studies, in addition to the quantitation of
a functional protein synthesis inside lipid vesicles [47], several
Fig. 1. Semi-synthetic minimal cells. (a) The semi-synthetic approach consists in the construction of a cell-like compartment based on the encapsulation of DNA, ribosomes,
tRNAs, enzymes and translation factors inside a lipid vesicle (liposome) at the aim of reconstructing a living cells containing the minimal number of molecular components.
From the technological viewpoint, this approach merges liposome- and cell-free-technologies. The PURE system represents today the standard tool for the semi-synthetic
approach. It includes 20 amino-acyl-tRNA synthases, 10 translation factors, T7 RNA polymerase, methionine-tRNA transformilase, 4 enzymes for the energy recycling, puriﬁed
ribosomes and tRNAs, and low molecular weight compounds such as amino acids, NTPs, salts and buffer. The 36 protein factors are over-expressed and puriﬁed in His-tagged
form without a loss in activity. [28,29]. Reproduced from reference [9] with permission from Elsevier. (b) Details of the droplet transfer method. (1) A solution of lipids in oil
(hydrocarbons) is stratiﬁed over an aqueous solution (outer-solution: ‘‘o-solution’’). In a second step (2), a lipid-stabilized water-in-oil emulsion, prepared by emulsifying a
small aliquot of an aqueous solution (inner-solution: ‘‘i-solution’’) in lipid containing oil (the lipid can be different than that one used for preparing the oil-water interface in
(1)), is poured above the oil/water interface prepared in (1). Water droplets tend to fall down toward the interface due to their higher density when compared to oil. By
crossing the lipid-containing oil/water interface (1) a droplet is covered by a second lipid layer, being transformed into a vesicle. The vesicles are generally collected by
centrifugation. Reproduced from [30] with minor modiﬁcations, with permission of Elsevier. (c) Protein synthesis inside GVs produced by the droplet transfer method, as
visualized by confocal laser scanning microscopy (left: bright ﬁeld; center: ﬂuorescence; right: overlay). Enhanced green ﬂuorescent protein (EGFP)-encoding DNA was mixed
with the PURE system as described elsewhere [31]. Giant vesicles were prepared as it follows: 5 lL of DNA/PURE systemmixture (including 100 mM sucrose) were emulsiﬁed
in 500 lL of 0.5 mM POPC in mineral oil (from Sigma, code M5904) by pipetting. The obtained w/o emulsion was gently poured above 500 lL of 0.5 mM POPC in mineral oil,
previously stratiﬁed over 500 lL of PURE system buffer (including 100 mM glucose). Collected by centrifugation (2000 rpm, 10 min), giant vesicles were then incubated at
37 C for 2 h.
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RNA synthesis on RNA template [17], the control of genetic expres-
sion by a two-stages cascade reaction [43], the formation of pore
on the liposome membrane, allowing the entrance of fresh ‘‘nutri-
ents’’ into the synthetic cell [44], the minimal size of a protein-
producing liposome [31], and the ﬁrst attempts to construct a
lipid-synthesizing synthetic cell [46,48]. The interested reader
can ﬁnd several more detailed technical discussions on the subject
of compartmentalized biochemical reactions – also including some
philosophical aspects – in some recent publications [22,49–51].
The most intriguing aspect of the construction of minimal cells
deals with the process of self-assembly of an ordered structure (the
compartment and the solutes encapsulated therein) from a mix-
ture of separated compounds and lipids. This process corresponds
practically (and conceptually) to the emergence of a ‘‘unit’’ that is
distinct from the environment, by virtue of its self-bounding prop-
erty. Thus, it is not an overstatement to emphasize that this is the
core step of minimal cell research. From the technical viewpoint,
however, it has been realized that this critical passage is also the
bottleneck of the semi-synthetic technology. In fact, it is wellknown that the spontaneous formation of lipid vesicles in a solu-
tion containing, for example, the transcription/translation kit, only
a fraction of the resulting compartment is viable, due to the difﬁ-
culty of co-entrapping all different molecular components inside
the same vesicle. This becomes a very critical factor when small
compartments are used. In a recent study, we pointed out that
the GFP synthesis inside 200 nm vesicles can only be explained
by assuming that the expected average number of encapsulated
molecules is actually exceeded due to local concentration effects
[31]. To test this hypothesis, a cryo-transmission electronmicros-
copy study on the encapsulation of ferritin [52] and ribosomes
[53] was carried out, bringing about the striking discovery that
the entrapment of these macromolecular solutes into conventional
vesicles does not obey to the expected Poisson statistics, but it is
rather shaped as in a power law distribution, with several empty
vesicles and few exceptionally ﬁlled ones. This phenomenon,
which is currently under investigation in our laboratory (aiming
at extending its validity to other proteins and to larger vesicles,
as well as at understanding its generative mechanism via stochas-
tic simulations), helps to explain how functional primitive cells,
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diluted solution.
Note that, puzzled by the anomalous entrapment hypothesis
(the ‘‘conundrum’’ of solute encapsulation [31]), we exploited the
SB approach to discover a novel physical mechanism underlying
the origin of cell and its metabolism.
However, the issue of solute encapsulation also triggered our
interest toward novel vesicle preparation methods. Inspired by
the 2003 report of Weitz and co-workers [54,55], we started a
through investigation of the so-called ‘‘droplet transfer’’ method
for producing giant vesicles (GVs). In particular we were interested
in this method because it brings about – with good reproducibility
– the facile entrapment of solutes into vesicles and bypasses the
(yet very interesting) problems associated to the statistics of mul-
ti-molecular co-entrapment. The ﬁrst step of this method consists
in the formation of stable (lipid-stabilized) water-in-oil droplets,
which contain the solute(s) of interest. Due to the presence of oil
around the droplets all solutes result conﬁned into the aqueous
droplet volume. The core of the droplet transfer technology lies
on the passage of solute(s)-ﬁlled, lipid-stabilized water-in-oil
droplets through a water/oil interface containing an oriented lipid
layer (ideally, a monolayer) (Fig. 1b). The water-in-oil droplet
acquires a second lipid layer when crossing the water/oil interface
and becomes a vesicle, still containing all solutes previously
conﬁned into the droplet. It is evident the advantage of this prep-
aration method when compared to others. The ‘‘all inside’’ geome-
try, typical of water-in-oil droplets, is topologically transferred to
form a vesicle already ﬁlled with the solute(s) of interest.
Details of the preparation method will be given in a next publi-
cation, however it can be anticipated that we have optimized the
GVs production by using different kinds of phospholipids, fatty
acids, synthetic surfactants and mixture of them. By tuning the vol-
umes of emulsion, emulsiﬁed phase, oil/water interface and outer
(collecting) solution, we were able to produce in reproducible
way about 5000 GVs/lL. Consequently, we have extended out
semi-synthetic cell technology to the reproducible preparation of
cationic and anionic GVs which entrap a wide range of water-sol-
uble solutes.
As an example of the application of this method, we encapsu-
lated all components of the PURE system and a gfp-encoding plas-
mid into GVs, and followed the production of GFP (Fig. 1c). As
already reported by other groups [44,56], this preparation method
is really advantageous when a complex liposome bioreactor needs
to be built. Interestingly, GVs prepared by the droplet transfer
method can also be sized down by extrusion. In this respect, we
plan to further exploit this method for constructing semi-synthetic
minimal cells designed to perform speciﬁc functions such as lipid
production, DNA or RNA replication, and especially core-and-shell
reproduction.
2.2. Future developments
As it has been shortly commented above, the state-of-the-art of
semi-synthetic minimal cell research is now focused to acquiring
the control of protein synthesis inside liposomes and to improve
the liposome preparation methods. Quite probably, this ‘‘transition
period’’, that follows the pioneering era, will precedes the next
phase of full development of complex functions in semi-synthetic
minimal cells.
Which are the most attractive goals? Certainly, if semi-
synthetic minimal cells are considered as model of primitive cells,
the most important goal will be the synchronized ‘‘core-and-shell’’
reproduction, namely, the coordinated replication of genetic mate-
rial inside the cell, together with all proteins and the ribosomes,
and the production of lipid molecules, so that the surface growth
will allow the cell growth. From this state, it might follow a celldivision (see the studies on self-reproduction of fatty acid vesicles
[57,58]). An interesting study on the replication of RNA as genetic
polymer inside lipid vesicles has been recently reported [17].
By noting that current approaches are based on feeding semi-
synthetic minimal cells with high-energy compounds like ATP,
another future development might involve the reconstruction of
molecular machines that are able to produce chemical energy
directly inside the synthetic cell. In this direction, the recent works
of Kuruma et al. [59,60] are worth of mention.
Additional research directions go toward the use of semi-syn-
thetic minimal cell as biotechnological tool, for example as mi-
cro-bioreactors for advanced drug delivery technologies [61],
taking advantage of their potential sensoring abilities, triggered
metabolic transformations, and target recognition.3. The Never Born Biopolymers: from the proteins to the RNA
Our work on Never Born Biopolymers lays within the frame-
work of the novel and unconventional approach dubbed ‘‘chemical
synthetic biology’’ [8–10], which, as already mentioned, is
concerned with the synthesis of chemical structures such as pro-
teins, nucleic acids, vesicular forms and other which do not exist
in nature.
This research speciﬁcally addresses the question of the design,
synthesis and analysis of completely de novo biopolymers (pro-
teins and RNAs), exploring the sequence space for novel biochem-
ical structures that do not exist in nature, to be exploited as novel
functional scaffolds for synthetic biology rather then try to answer
scientiﬁc basic questions on origin of life [9,10]. In particular, the
aim of developing completely de novo biopolymers (Never Born
Proteins (NBPs) and Never Born RNAs (NB-RNAs)) could unveil an
immense reservoir of potentialities that could tremendously enrich
our knowledge and biotechnology.
The rationale behind these projects relies on the observation
that the number of natural proteins and RNAs on our Earth,
although apparently large, is only an inﬁnitesimal fraction of the
possible ones. This means that there are an astronomically large
number of proteins and RNAs that have never been sampled by
natural evolution on Earth awaiting human exploration and exploi-
tation [62,63].3.1. Never Born Proteins
As already mentioned, the rationality behind this project relies
on the observation that the number of natural proteins on our
Earth, although apparently large, is only a tiny fraction of all the
possible ones. Indeed, speaking about proteins, there are thought
to be roughly 1013 proteins of all sizes in extant organisms. This
apparently huge number represents less than noise when com-
pared to the number of all theoretically possible different proteins
[64]. The discrepancy between the actual collection of proteins and
all possible ones stands clear if one considers that the number of all
possible 50 residue peptides that can be synthesized with the stan-
dard 20 amino acids is 2050, namely 1065. Moreover, the number of
theoretically possible proteins increases with length, so that the
related sequence space is beyond contemplation; in fact, if we take
into account the living organisms, where the average length of
proteins is much greater, the number of possible different proteins
becomes even bigger [65]. The difference between the number of
possible proteins and the number of those actually present in liv-
ing organisms is comparable, in a ﬁgurative way, to the difference
that exists between a drop of water and an entire Ocean [22]. This
means that there is an astronomically large number of proteins
that have never been subjected to the long pathway of natural evo-
lution on Earth: the ‘‘Never Born Proteins’’ (NBPs). Furthermore,
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result of natural selection is of the utmost importance to elucidate
the role of proteins in the origin of life and to fully exploit its bio-
logical potential and ﬁnd new scaffolds for biological activities
[10,22].
The use of random sequences to create protein libraries to
search for new active sequences in both, pharmaceutical applica-
tion and basic science research is a relatively commonplace
[66–67].
Respect to our approach the difference is based on the kind of
randomization applied; whereas usually the protein libraries pro-
duced are only partially randomized (directed randomization
[68]) in our case we use a total randomization approach [62]. In
the directed randomization the researcher uses natural scaffolds
to engraft short random peptides or to mutate restricted regions
of a target protein, whereas the rest of the sequence is left
unchanged. In contrast, our libraries are constituted by de novo
totally random sequences [62] with no preconception as to what
their properties might be.
In the preliminary work we set up a method to test, as a ﬁrst
approximation threshold, the folding stability of the random
library, introducing a very short sequence (a tripeptide) substrate
for a protease into the random sequence. The proteins with a stable
fold are much more resistant to proteolytic digestion than
unfolded ones [69–72], resulting preferred during selection cycles
(Fig. 2a).
The work until now has been to set up an efﬁcient protocol for
the production and study of NBPs and, in particular, the production
of large libraries (of the order of 108–9 clones) of totally random
proteins (with 50 and 20 residues) by phage display (Fig. 2b)
[9–10,62]. The NBPs analyzed by spectroscopic methods reveal a
word of novel structured sequences with a great potential in terms
of properties.
Indeed, NBPs pose a series of challenging questions in basic and
applied science: do they present novel principles of structure?
Have they any, possibly novel, catalytic properties? Do they elicitFig. 2. Never Born Biopolymers. (a) Schematic representation of the NBPs selection syst
random sequences is a tripeptide substrate for the protease. The tag serves to bind t
Schematic representation of the three-dimensional structure of few selected random pro
web server (http://robetta.bakerlab.org). (c) Structural redundancy of the RNA sequence
the different sequences generable for a given length l. Different sequences of RNA (blac
structure. This indicates that sequence/structure space is many-to-one. (d) Schematic
nucleasic activity of nuclease S1, which is acted on single strand RNAs. In fewer words
secondary and eventually tertiary structure. (e) RNA Foster on a single Never Born RNA pr
black) at the different temperatures. The fraction of folded RNA for each temperatur
corresponds to the amount of uncleaved RNA after S1 incubation. The random sequen
population average (18 random sequences) (in light gray).the formation of antibodies? Are they compatible with extant life
forms? Do they represent novel therapeutic agents?
3.2. Never Born RNAs
Likewise described for random protein, the study of random
RNAs poses a lot of considerations to take into account. A single
RNA sequence is only a point in a 4l space of all the possible
sequences of a given length l [22,73]. This dimension 4l comes from
the fact that for a given polymer of length l, 4l is the number of all
the possible generable sequences, being each position of the
sequence occupied by one of the four nucleobases.
Several independent investigations have shown that for a ﬁxed-
length polynucleotide, the number of different generable sequences
far exceeds the number of the possible structures. Schuster and col-
leagues [73], using an inverse folding algorithm to calculate the
number of different sequences with the same secondary structure,
found that the sequence-space structures is the type of many-to-
one (Fig. 2c) and that the different sequences that take the same
shape are spread evenly in the space of sequences, showing a small
or none homology degree [74]. These theoretical indications are
experimentally conﬁrmed by the observation that only seven
nucleotides are strictly conserved in the intron self-splicing group
I [75], although the secondary structure of the ribozyme and its
function are preserved. This case clearly illustrates the fact that se-
quences with little or no homology can achieve the same structure
and perform the same function in spite of the diversity of their
sequences.
The reasons behind the redundancy of the sequence/structure
space of RNA can be found in the modular organization of the
secondary structure of the RNA. Knight and colleagues have high-
lighted how RNA molecules are organized into independent func-
tional domains connected by ﬂexible spacers, whose sequences
are irrelevant for the secondary and tertiary structures [76]. In this
work they developed a method to calculate the abundance of these
functional domains, in a pool of random RNA sequences. Theem. The random peptide library is bound to the bacteriophage. In the middle of the
he speciﬁc antibody during the selection of the protease-resistant sequences. (b)
teins using the ab-initio modelling program Rosetta as implemented in the Robetta
space. The gray sphere represents the potential diversity of molecular species, i.e. all
k spots inside the sphere), with little or no homology, could fold getting the same
representation of the RNA Foster assay. It combines the thermal incubation with
, the most stable sequences at high temperature will be those with a more stable
esenting a good stability at 70 C. Plot showing the residual random RNA amount (in
e is estimated by image analysis of the band intensity on PAGE urea gel, which
ce stability is compared with the one of the natural tRNA (in gray) and the RNA
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increases the redundancy of the sequence/structure space, since
the number of ways that can be achieved a speciﬁc fold increases
markedly due to the modularity of the domains of RNA.
In addition, the RNA secondary motifs, crucial for ribozymic
activity, are due to the annealing of complementary bases that fol-
low the Watson and Crick rules (A:U and C:G), increasing even
more the probability of ﬁnding these domains in different regions
of the sequences space and inside sequences no related to each
other [77].
The simple consequence of these results is that the RNA
sequence space is rich in folded RNAs. In addition, the RNA
sequence/structure space seems to be characterized by a high
redundancy of related sequences that share the same structure
and probably the same function too.
Starting from the considerations on the structural redundancy
of the sequence space, i.e. sequences with low homology may take
the same structure, a comprehensive research has been under-
taken in our group to study the structural properties of random
RNAs, that is the draft of the Never Born RNAs (NB-RNAs) project
[22].
On this basis we decided to explore the RNA sequence space in
search of random RNA molecules that have a stable folding at high
temperatures, by an assay set up in our lab: the RNA Foster (RNA
Folding Stability Test). This approach is based on the digestion of
RNAs by S1 nuclease, a single-strand-speciﬁc nuclease, at several
temperatures to determine the presence and thermal stability of
secondary domains by coupling enzymatic digestion with temper-
ature denaturation (Fig. 2d). The assay is capable to quantitatively
determine the fraction of folded RNAs (ffold) as a function of the
temperature [78].
The resistance to S1 nuclease digestion depends on the RNA
fold, in fact, the unfolded RNAs are degraded faster than the folded
ones. A temperature increment destabilizes the RNA fold, inducing
either global or local unfolding. Using nuclease S1, capable to work
over a broad range of temperatures, is possible to probe RNA sec-
ondary domain stability. Measuring the amount of RNA remaining
after S1 digestion using electrophoresis and a suitable staining
method, it is feasible to determine the fraction of folded RNA (ffold)
and to assess the Tm of the RNA molecules at each experimental
temperature. The Foster assay has several advantages: the simplic-
ity and rapidity of execution, the requirement of simple instru-
mentation, and in particular the minimal RNA amount required.
In general, this methodology has one most notable advantage: it
is a timesaving technique. Therefore, it is suitable for the screening
of large libraries and could be easily adapted for high-throughput
studies, like in vitro selection experiments [79].
For our studies we have prepared a library of de novo RNAs,
containing 60 totally random residues ﬂanked by a pair of constant
regions for operational reasons, asking the question on stability:
whether or not, and to what extent these totally random RNA
sequences are able to exhibit a stable compact fold.
A stable and well-deﬁned fold is a fundamental prerequisite for
the biological activity of extant biopolymers, and this applies to
RNAs as well. Accordingly, in order to exploit the potential of ran-
dom RNA sequences – Never Born RNAs – as a scaffold for chemical
synthetic biology one must determine whether and to what extend
random RNAs adopt a stable and well-deﬁned fold.
Until now the most general result of our studies lies in the
demonstration that RNAs have the capacity to fold into compact
secondary structures, even in absence of selective pressure [63].
This conﬁrm our hypothesis that molecules involved in nowadays
life do not have exclusive features at far as the ability to adopt a
stable fold is concerned.
In detail, the RNA Foster was successfully used to evaluate the
structural properties of 18 random RNAs. RNA molecules weretested individually at 4 different temperatures, in order to evaluate
their ability to form internal double helices and, thus, to acquire
secondary and tertiary structures. The results were used to assess
the temperature of the main unfolding transition of individual
RNAs. The experimental data show that almost all screened RNAs
possess folded structures at 30 C. Furthermore, half of the sam-
pled RNAs maintain the fold up to 50 C. Surprisingly, one se-
quence presents a good stability at 70 C showing a melting
temperature close to the same degree value (Fig. 2e). Moreover,
two sequences are more stable than the standard tRNA at the same
temperature (70 C) [63].
In light of the results obtained from the studies on the stability
of single Never Born RNAs by RNA Foster, we decided to extend our
analysis to a larger number of RNAs, in order to investigate the per-
centage of stable sequences at high temperatures found in a ran-
dom RNA population.
With this aim we used the in vitro selection [80] to select the
random RNA library. Beginning with a broad population of RNAs
we applied a selective pressure, then we recovered, reverse-
transcripted and ampliﬁed those molecules that satisfy the estab-
lished condition.
We found that, according to our predictions, the diversity of the
RNA population tends to decrease as the selection keeps on, indi-
cating a skimming working on it. Moreover, one of the sequences
analyzed is more stable than the tRNA, taken as control, at 70 C,
with an approximately melting temperature higher than 80 C
(details will be given in a next publication).
Even though the limited number of sequences explored is not
statistically signiﬁcant, the most general result of our studies lies
in the demonstration that RNAs have the capacity to fold into com-
pact structures, even in the absence of selective pressure. In other
words, folding capability is a relatively common property, almost
an intrinsic feature, of RNAs, as already mentioned in our previous
work for longer RNAs [81].
3.3. Potential impact and future goals
The potential impact of this research is twofold, spanning from
basic to applied science. From the basic science standpoint, the
study of the structure of biopolymers that do no exist in nature will
permit us to establish whether additional principles of structure
stability may be present in the folding of proteins and RNAs. If no-
vel structural elements will be found, these could be used as scaf-
folds for a new kind of structural chemistry of proteins and RNAs,
which can be useful also from the biotechnological standpoint.
From the applied science standpoint, Never Born Biopolymers
(NBBs) will represent completely novel scaffolds for synthetic biol-
ogy applications. It is well known that enzymes ﬁnd several appli-
cations in biotechnology and chemical industry as speciﬁc
catalysts or in general as active therapeutic molecules. The search
for catalytic properties in the NBBs can therefore be relevant for
applied science. Notice that NBBs are completely orthogonal (insu-
lated) to extant organisms and therefore may be implemented into
synthetic biology chassis possibly reducing cross talk and parasitic
effects. In addition, NBBs – unlike natural polymers – are not the
results of any evolutionary pathway and can therefore be regarded
as virgin polymers which functionality can be engineered without
constrictions to meet the user’s requirements.
To this regard, NBBs may pave the way for novel design para-
digms in synthetic biology and applications in metabolic engineer-
ing and ﬁne-chemical production as well as complex system
engineering. It is also well known that proteins and polypeptides
in general are therapeutical agents, for example several proteins
are used as inhibitors or for example as anti-inﬂammatory drugs.
On the basis of all this, the selected clones of the NBBs could be
screened for a series of potential therapeutical activities.
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The common notion of synthetic biology refers to new forms of
microbial life obtained through genetic manipulation of the extant
life forms – a classic bioengineering approach. The few pages of the
present review make however clear that synthetic biology has an
additional dimension, that related to the term ‘‘chemical synthetic
biology’’. Here, the production of biological structures alternative
to the natural ones is carried out by using chemical and biochem-
ical technology: we have seen in this review application of the
physico-chemistry of vesicles, the ribosomal protein synthetic
apparatus, peptide catalysis, enzymatic assays, etc.
It is apparent that this approach is yielding a rich variety of
novel forms and corresponding novel ideas, which may be relevant
for our understanding of basic science – but also potentially inter-
esting from the biotechnological point of view. Thus, the minimal
cell project can bring us to a better understanding of the emer-
gence of life on simple chemical ground- but can also offer a novel
form of device for enzyme delivery system, or of entire metabolic
pathways. And the NBPs can help us understanding why nature
has chosen that particular family of proteins and not another
one- at the same time possibly providing us with new catalytic
functions. We ascribe now particular interest in the NB-RNAs, as
this can help solving some still intriguing obscure points in the
RNA world.
It is also worth of note that the research on chemical synthetic
biology has brought us, as a consequence, to the discovery of new
aspects of the chemistry of compartmentation – the overcrowding
effect that we consider now a possible origin of cellular metabo-
lism in the origin of life. The NBPs can provide novel structures
and novel forms of catalysis – possibly even novel form of thera-
peutic agents. Also interesting is the discovery that randomly
designed RNAs can assume structures that are resistant to rela-
tively high temperatures without having being optimized by
evolution.
It is a large ﬁeld in which basic science and applicative research
combine together, and we are conﬁdent that signiﬁcant progress is
waiting ahead of us.
5. Box 1. Fragment condensation and organocatalysis
Another problem that can be approached by chemical synthetic
biology concerns the stepwise construction of polypeptides (or
polynucleotides) from short segments [22–23]. This scenario is
also linked to the emergence of a ‘‘dynamic chemical network’’
(the model of spontaneously arising self-catalytic sets, as sug-
gested by Stuart Kauffman [24], is an example of such scenarios).
Not many experimental studies deal with this or similar systems,
which have, however, several intriguing conceptual aspects.
The key idea is that short oligomers, formed spontaneously by
random oligomerization processes, are joined together to give
longer sequences, which in turn can condense again and produce
a biopolymer of sufﬁcient length to fold and possibly have a cata-
lytic site. A selection process might operate to reduce the huge
combinatorial diversity that can be generated by this mechanism,
for example removing sequences that can be easily cleaved, or
insoluble ones. Amphiphilic sequences can be adsorbed on mem-
branes, if available. To make possible this pathway, that resembles
the convergent synthesis of complex organic molecules, it is neces-
sary to join together the reactive end groups of oligomers. In the
case of polypeptide, this means that an amide bond should be
formed between a terminal amino group and a terminal carboxylic
group, possibly in activated form. Is it possible to ﬁnd a catalyst –
possible a simple one – that can help this reaction? An attractive
answer deals with small molecule catalysis, i.e., ‘‘organocatalysis’’.In 2000 Zhao and co-workers described that Ser-His and other
similar small peptides have an esterase and protease activity
[25]. Inspired by this intriguing ﬁnding, we studied whether Ser-
His, being able to cleave amide bonds, was also able to catalyze
the reverse reaction, i.e., forming amide bonds. The striking result
was that – although in low yields and only for products with low
solubility – Ser-His acts as a reverse protease and brings about
the formation of di-, tri- and tetra-peptides, starting from an amino
acid ester (a C-activated form) and a free amino group of amino
acids or dipeptides. In addition to the synthesis of oligopeptides,
Ser-His could produce also peptide-nucleic acids (PNAs) oligomers
(up to 4 residues long) [26]. This reaction, at the moment, is limited
to insoluble short products. However, it provides a proof of con-
cepts that in particular experimental conditions, it is possible to
combine ‘‘fragments’’ to give longer molecules. If Ser-His (or simi-
lar small organocatalysts) could act as a catalyst for binding to-
gether short oligopeptides or oligonucleotides, this would allow
the synthetic reconstruction of a combinatorial biopolymer net-
work from short building blocks. In turn, the newly synthesized
longer oligomers could also display catalytic activities (perhaps
more speciﬁc) and take part to the auto- or cross-catalysis in the
entire network [22,23]. Again, these compounds do not exist in
nature, but can be investigated by a chemical synthetic biology ap-
proach. In addition to their relevance for primitive life scenarios,
these studies can trigger biotechnological or chemical progresses.References
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